Jpmorgan Chase & CO Dyadic International Inc Transaction History
Jpmorgan Chase & CO
- $1.22 Trillion
- Q3 2024
A detailed history of Jpmorgan Chase & CO transactions in Dyadic International Inc stock. As of the latest transaction made, Jpmorgan Chase & CO holds 29 shares of DYAI stock, worth $49. This represents 0.0% of its overall portfolio holdings.
Number of Shares
29
Previous 29
-0.0%
Holding current value
$49
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding DYAI
# of Institutions
36Shares Held
4.77MCall Options Held
20.6KPut Options Held
0-
Bandera Partners LLC New York, NY1.57MShares$2.66 Million0.62% of portfolio
-
Chapin Davis, Inc. Baltimore, MD868KShares$1.48 Million0.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA806KShares$1.37 Million0.0% of portfolio
-
Northeast Financial Consultants Inc Westport, CT250KShares$425,0000.01% of portfolio
-
Black Rock Inc. New York, NY249KShares$423,6140.0% of portfolio
About DYADIC INTERNATIONAL INC
- Ticker DYAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,423,100
- Market Cap $48.3M
- Description
- Dyadic International, Inc., a biotechnology platform company, develops, produces, and sells enzymes and other proteins in the United States. The company utilizes its patented and proprietary C1 platform and other technologies to conduct research, development, and commercial activities for the development and manufacturing of human and animal vac...